undamentalytics Newsletter
Sign in

Imagenebio, Inc. balance sheet

At the end of fiscal 2025, Imagenebio, Inc. had total assets of $153m, total liabilities of $19.8m and shareholders' equity of $133m. It held $94.5m in cash against $0 of debt: net cash of $94.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash and equivalents162232601201295
Total current assets16623716017912140
Total assets16824817219216153
Accounts payable222251
Deferred revenue (current)21179—10
Total current liabilities282722141711
Short-term debt————80
Total debt000190
Total liabilities634025221720
Shareholders' equity−101208147−126−161133
Non-controlling interests and other (assets − liabilities − equity)206——296159—
Net debt (negative = net cash)−162−232−60−119−4−95

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IMA vs MNOVIMA vs STTKIMA vs LGVN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Imagenebio, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Imagenebio, Inc.